Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases

PURPOSE: To examine the evidence on the cost-effectiveness of implementing pharmacogenomics (PGx) in cardiovascular disease (CVD) care. METHODS: We conducted a systematic review using multiple databases from inception to 2018. The titles and abstracts of cost-effectiveness studies on PGx-guided trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genet Med
Main Authors: Zhu, Ye, Swanson, Kristi M., Rojas, Ricardo L., Wang, Zhen, St. Sauver, Jennifer L., Visscher, Sue L., Prokop, Larry J., Bielinski, Suzette J., Wang, Liewei, Weinshilboum, Richard, Borah, Bijan J.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group US 2019
Assuntos:
Systematic Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056639/
https://ncbi.nlm.nih.gov/pubmed/31591509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-019-0667-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados